New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
16:37 EDTWXWuXi PharmaTech narrows FY12 revenue view to $495M-$498M from $488M-$498M
FY12 consensus $496.85M. Sees FY12 operating margin of about 17.5% on a GAAP basis and about 20.5% on a non-GAAP basis, compared to previous guidance of 17%-18.0% and 20.0%-21.0%, respectively.
News For WX From The Last 14 Days
Check below for free stories on WX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
08:01 EDTWXWuXi PharmaTech passes FDA inspection for manufacture of API
Subscribe for More Information
August 13, 2014
16:43 EDTWXWuXi PharmaTech sees Q3 EPS 48c-50c, consensus 49c
Subscribe for More Information
16:41 EDTWXWuXi PharmaTech raises FY14 EPS view to $1.82-$1.86 from $1.80-$1.85
Subscribe for More Information
16:34 EDTWXWuXi PharmaTech reports Q2 EPS 49c, consensus 47c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use